Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TT3WG5C)

• DTT Name: Monoamine oxidase type A (MAO-A) DTT Info
• Gene Name: MAOA

Molecule-Related Drug & Molecule List

4 Approved Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Clorgyline	DMCEUJD	Parkinson disease	8A00.0	Approved	[1]
Isocarboxazid	DMAF1NB	Depression	6A70-6A7Z	Approved	[2]
Moclobemide	DMNZWL7	Depression	6A70-6A7Z	Approved	[3]
Tranylcypromine	DMGB5RE	Major depressive disorder	6A70.3	Approved	[4]

7 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Psoralen	DMIZJ8M	N. A.	N. A.	Phase 3	[5]
TRYPTAMINE	DMAFPHB	N. A.	N. A.	Phase 3	[6]
CHF-3381	DMQ2O8V	Neuropathic pain	8E43.0	Phase 2	[7]
CX157	DMS2WB5	Mood disorder	6A60-6E23	Phase 2	[8]
Ladostigil	DMJSY3Q	Alzheimer disease	8A20	Phase 2	[9]
PIPERINE	DMYEAB1	Vitiligo	ED63.0	Phase 1/2	[10]
Desoxypeganine	DMTR7EH	Alcohol dependence	6C40.2	Phase 1	[11]

39 Patented Agent(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AphanamgrandiolA	DMLQ8N1	N. A.	N. A.	Patented	[12]
Cyclic peptide derivative 1	DM78NOU	N. A.	N. A.	Patented	[13]
GypensapogeninA	DMFHC0O	N. A.	N. A.	Patented	[12]
GypensapogeninB	DMX4ET5	N. A.	N. A.	Patented	[12]
Harmine	DMPA5WD	Discovery agent	N.A.	Patented	[14]
Heteroaryl-cyclopropylamine derivative 1	DMRF58Q	N. A.	N. A.	Patented	[13]
HouttuynoidA	DMU5JC0	N. A.	N. A.	Patented	[12]
IncarviatoneA	DMBURAZ	N. A.	N. A.	Patented	[12]
KadcoccitoneA	DM7UK5E	N. A.	N. A.	Patented	[12]
MyriberineA	DMA8BLZ	N. A.	N. A.	Patented	[12]
N-(2-phenylcyclopropyl) amino acid derivative 3	DMFBRSL	N. A.	N. A.	Patented	[13]
PhyllanthoidA	DM5H3R8	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure1-Aphanamixoid A	DM23NEX	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure1-Chukrasone A	DMRHNOY	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure1-Chukrasone B	DM0K4XE	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure1-Eryngiolide A	DMDX1MK	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure1-Neonectrolide A	DMSYGHO	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure1-Sarcaboside A	DMRIEH3	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure1-Sarcaboside B	DMDL6TG	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure2-Artoxanthochromane	DMG1EKV	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure2-Spirooliganone B	DMYJ0I8	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure3-Aspeverin	DMP5Y19	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure3-Fluevirosine A	DM9KTRA	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure3-Lycojaponicumin A	DMBSP1G	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure3-Lycojaponicumin B	DMKP64Z	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Figure3-Lycojaponicumin C	DM7NUT2	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Table 5-8	DMLAS7K	N. A.	N. A.	Patented	[12]
PMID25399762-Compound-Table 5-O-methyl-M30	DM18FP4	N. A.	N. A.	Patented	[12]
PMID29324067-Compound-25	DM0DAR1	N. A.	N. A.	Patented	[15]
PMID29757691-Compound-4	DMFD9UZ	N. A.	N. A.	Patented	[16]
Schiff base compound 1	DMQD6IL	Alzheimer disease	8A20	Patented	[15]
Secondary and tertiary (hetero)arylamide derivative 2	DMIES9B	N. A.	N. A.	Patented	[15]
Tacrine-coumarin hybrid derivative 1	DM6YBTR	N. A.	N. A.	Patented	[15]
Tarnylcypromine derivative 2	DMEJR2F	N. A.	N. A.	Patented	[13]
Tarnylcypromine derivative 3	DMKJOMC	N. A.	N. A.	Patented	[13]
Tetra-hydro-isoquinoline derivative 1	DML86IO	N. A.	N. A.	Patented	[16]
Tetra-hydro-isoquinoline derivative 2	DM5CKVF	N. A.	N. A.	Patented	[16]
Tetra-hydro-isoquinoline derivative 3	DMCZA45	N. A.	N. A.	Patented	[16]
Tetra-hydro-isoquinoline derivative 4	DMDV0MP	N. A.	N. A.	Patented	[16]

9 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Befloxatone	DMZIV6D	Major depressive disorder	6A70.3	Discontinued in Phase 3	[17]
Brofaromine	DMTEQ0G	Anxiety disorder	6B00-6B0Z	Discontinued in Phase 2	[18]
CS-722	DMGYXA4	Epilepsy	8A60-8A68	Discontinued in Phase 2	[19]
Esuprone	DM1DHOT	Major depressive disorder	6A70.3	Discontinued in Phase 2	[20]
RS-8359	DMERM0K	Major depressive disorder	6A70.3	Discontinued in Phase 2	[21]
AS602868	DMKXDOI	Multiple myeloma	2A83	Discontinued in Phase 1	[5]
BW-1370U87	DM296HE	Major depressive disorder	6A70.3	Discontinued in Phase 1	[22]
Bifemelane	DMU73F0	Alzheimer disease	8A20	Terminated	[23]
E-2011	DMD4GQ8	Anxiety disorder	6B00-6B0Z	Terminated	[24]

177 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
(+/-)-2-(4'-Benzyloxyphenyl)thiomorpholine	DMCB74T	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Butoxyphenyl)thiomorpholin-5-one	DM1WCJV	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Butoxyphenyl)thiomorpholine	DMG3MF2	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholin-5-one	DM1YBJ2	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Ethoxyphenyl)thiomorpholine	DMKPX7W	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Methoxyphenyl)thiomorpholin-5-one	DM7BY4T	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Methoxyphenyl)thiomorpholine	DMKFSQ8	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Propoxyphenyl)thiomorpholin-5-one	DMY1W20	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-(4'-Propoxyphenyl)thiomorpholine	DMUPYN1	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-Phenylthiomorpholin-5-one	DMSHDNO	Discovery agent	N.A.	Investigative	[25]
(+/-)-2-Phenylthiomorpholine	DMNR3YL	Discovery agent	N.A.	Investigative	[25]
(6-Benzyloxy-2-naphthyl)-2-aminopropane	DMF7LST	Discovery agent	N.A.	Investigative	[26]
(6-Butoxy-2-naphthyl)-2-aminopropane	DM7BK9A	Discovery agent	N.A.	Investigative	[26]
(6-Ethoxy-2-naphthyl)-2-aminopropane	DMM2EX6	Discovery agent	N.A.	Investigative	[26]
(6-Methoxy-2-naphthyl)-2-aminopropane	DM6YGQ3	Discovery agent	N.A.	Investigative	[26]
(6-methylthio-2-naphthyl)isopropylamine	DM39W5K	Discovery agent	N.A.	Investigative	[26]
(6-Propoxy-2-naphthyl)-2-aminopropane	DMIFL3V	Discovery agent	N.A.	Investigative	[26]
(7-Benzyloxy-2-oxo-2H-chromen-4-yl)acetonitrile	DMB9YAO	Discovery agent	N.A.	Investigative	[27]
(E)-5-(3-Chlorostyryl)isatin	DMLIQUA	Discovery agent	N.A.	Investigative	[28]
(E)-5-(3-Fluorostyryl)isatin	DMP4T9Z	Discovery agent	N.A.	Investigative	[28]
(E)-5-Styrylisatin	DM1PCIX	Discovery agent	N.A.	Investigative	[28]
(R)-Indan-1-yl-methyl-prop-2-ynyl-amine	DMKFPMC	Discovery agent	N.A.	Investigative	[29]
(R,S)-N-(R-phenylethyl)-1H-pyrrole-2-carboxamide	DMPDO43	Discovery agent	N.A.	Investigative	[30]
(R/R)BEFLOXATONE	DM8I6MG	Discovery agent	N.A.	Investigative	[31]
(S)-2-amino-1-(4-butylthiophenyl)-propane	DMPQ53V	Discovery agent	N.A.	Investigative	[32]
(S)-2-amino-1-(4-ethylthiophenyl)-propane	DMFK7O1	Discovery agent	N.A.	Investigative	[32]
(S)-2-amino-1-(4-methylthiophenyl)-propane	DM06NUM	Discovery agent	N.A.	Investigative	[32]
(S)-2-amino-1-(4-propylthiophenyl)-propane	DMAN7YJ	Discovery agent	N.A.	Investigative	[32]
1,2,3,4-Tetrahydro-pyrazino[1,2-a]indole	DM3JGVF	Discovery agent	N.A.	Investigative	[33]
1-(1-Naphthyl)-2-aminopropane	DM6X9J3	Discovery agent	N.A.	Investigative	[26]
1-(2-Naphthyl)-2-aminopropane	DMBNZKH	Discovery agent	N.A.	Investigative	[26]
1-(3-(4-chlorobenzyl)quinoxalin-2-yl)hydrazine	DMM36DE	Discovery agent	N.A.	Investigative	[34]
1-(3-benzyl-6,7-dichloroquinoxalin-2-yl)hydrazine	DMTY41F	Discovery agent	N.A.	Investigative	[34]
1-(3-benzylquinoxalin-2-yl)hydrazine	DMJCVQN	Discovery agent	N.A.	Investigative	[34]
1-(4-(benzyloxy)phenyl)propan-2-amine	DMT81N3	Discovery agent	N.A.	Investigative	[26]
1-(4-butoxyphenyl)propan-2-amine	DM7GIZL	Discovery agent	N.A.	Investigative	[26]
1-(4-ethoxyphenyl)propan-2-amine	DMZR94D	Discovery agent	N.A.	Investigative	[26]
1-(4-propoxyphenyl)propan-2-amine	DMKNA5U	Discovery agent	N.A.	Investigative	[26]
2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole	DMX8NYD	Discovery agent	N.A.	Investigative	[6]
2-(2-cycloheptylidenehydrazinyl)-4-phenylthiazole	DM187UQ	Discovery agent	N.A.	Investigative	[35]
2-(2-cyclopentylidenehydrazinyl)-4-phenylthiazole	DMH1VCE	Discovery agent	N.A.	Investigative	[35]
2-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-imidazole	DMLOX0Y	Discovery agent	N.A.	Investigative	[36]
2-(3-benzylquinoxalin-2-ylamino)ethanol	DM6V91D	Discovery agent	N.A.	Investigative	[34]
2-(4,5-dihydro-1H-imidazol-2-yl)quinoline	DM4X0SJ	Discovery agent	N.A.	Investigative	[36]
2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazole	DM0KUMX	Discovery agent	N.A.	Investigative	[36]
2-(5-phenyl-furan-2-yl)-4,5-dihydro-1H-imidazole	DMDZ9RK	Discovery agent	N.A.	Investigative	[37]
2-(naphthalen-2-yl)-4,5-dihydro-1H-imidazole	DMKY71Z	Discovery agent	N.A.	Investigative	[36]
2-Amino-1-(4-methylthiophenyl)propane	DMJ2Z9G	Discovery agent	N.A.	Investigative	[26]
2-BFi	DMFAW4R	Discovery agent	N.A.	Investigative	[38]
2-Bromo-N-(2-morpholinoethyl)nicotinamide	DMYCENM	Discovery agent	N.A.	Investigative	[39]
2-Chloro-N-(2-morpholinoethyl)nicotinamide	DMR8M36	Discovery agent	N.A.	Investigative	[39]
2-Chloro-N-(3-morpholinopropyl)nicotinamide	DM5S1DW	Discovery agent	N.A.	Investigative	[39]
2-Furan-2-yl-4,5-dihydro-1H-imidazole	DMQIFJ9	Discovery agent	N.A.	Investigative	[40]
2-oxo-N-m-tolyl-2H-chromene-3-carboxamide	DMDKSZ0	Discovery agent	N.A.	Investigative	[41]
2-oxo-N-p-tolyl-2H-chromene-3-carboxamide	DMWXI6C	Discovery agent	N.A.	Investigative	[41]
2-oxo-N-phenyl-2H-chromene-3-carboxamide	DMH8QWY	Discovery agent	N.A.	Investigative	[41]
2-Phenethyl-4,5-dihydro-1H-imidazole	DM4H6PC	Discovery agent	N.A.	Investigative	[40]
2-Phenoxymethyl-4,5-dihydro-1H-imidazole	DM5E74G	Discovery agent	N.A.	Investigative	[40]
2-phenyl-5H-indeno[1,2-d]pyrimidine	DMMDS2T	Discovery agent	N.A.	Investigative	[42]
2-phenyl-9H-indeno[2,1-d]pyrimidine	DMMHSYV	Discovery agent	N.A.	Investigative	[42]
2-[7-(Benzyloxy)-2-oxo-2H-chromen-4-yl]acetamide	DMZFKDW	Discovery agent	N.A.	Investigative	[27]
3,4-Benzo-7-(beta-bromoallyloxy)-8-methylcoumarin	DMN4Z27	Discovery agent	N.A.	Investigative	[43]
3,4-Benzo-7-acetonyloxy-8-methoxycoumarin	DM1MC06	Discovery agent	N.A.	Investigative	[43]
3,4-Benzo-7-acetonyloxy-8-methylcoumarin	DMKC6L8	Discovery agent	N.A.	Investigative	[43]
3,4-Dichloro-N-(2-methyl-1H-indol-5-yl)benzamide	DMMZURL	Discovery agent	N.A.	Investigative	[44]
3-aminoacetamido-4'-methylfuro[3,2-g]coumarin	DM0GJZM	Discovery agent	N.A.	Investigative	[45]
3-benzyl-N-(2-morpholinoethyl)quinoxalin-2-amine	DMZIOJS	Discovery agent	N.A.	Investigative	[34]
3-Chloro-N-(2-methyl-1H-indol-5-yl)benzamide	DMIEZGD	Discovery agent	N.A.	Investigative	[44]
3-methyl-2(1H)-thioxo-4(3H)-quinazolinone	DMHVNQM	Discovery agent	N.A.	Investigative	[46]
4,8-Dimethyl-7-(2'-oxocyclohexyloxy)coumarin	DMQNXL1	Discovery agent	N.A.	Investigative	[43]
4,9-Dihydro-3H-beta-carboline	DM27HMT	Discovery agent	N.A.	Investigative	[33]
4-(2-oxo-2H-chromene-3-carboxamido)benzoic acid	DMWIALU	Discovery agent	N.A.	Investigative	[41]
4-(Aminomethyl)-7-(benzyloxy)-2H-chromen-2-one	DMTB80W	Discovery agent	N.A.	Investigative	[27]
4-Chloro-N-(2-morpholinoethyl)nicotinamide	DMVCLP8	Discovery agent	N.A.	Investigative	[39]
4-Chloro-N-(3-morpholinopropyl)nicotinamide	DMM8G6H	Discovery agent	N.A.	Investigative	[39]
4-methyl-2H-benzofuro[3,2-g]chromen-2-one	DMKRHQ3	Discovery agent	N.A.	Investigative	[45]
4-methyl-7-(2-oxocyclopentyloxy)-2H-chromen-2-one	DM9K7CQ	Discovery agent	N.A.	Investigative	[43]
5,6-Dichloro-N-(2-morpholinoethyl)nicotinamide	DMR2OMU	Discovery agent	N.A.	Investigative	[39]
5,6-Dichloro-N-(3-morpholinopropyl)nicotinamide	DMZL87A	Discovery agent	N.A.	Investigative	[39]
5-Azidomethyl-3-pyrrol-1-yl-oxazolidin-2-one	DM0HO6C	Discovery agent	N.A.	Investigative	[31]
5-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMMI4H3	Discovery agent	N.A.	Investigative	[6]
5-Bromo-4,9-dihydro-3H-beta-carboline	DM2SEFR	Discovery agent	N.A.	Investigative	[6]
5-Hydroxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	DMT9FQN	Discovery agent	N.A.	Investigative	[31]
5-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMNRSYA	Discovery agent	N.A.	Investigative	[6]
5-Methoxy-4,9-dihydro-3H-beta-carboline	DMBOMZE	Discovery agent	N.A.	Investigative	[6]
5-Methoxymethyl-3-pyrrol-1-yl-oxazolidin-2-one	DMJ1HX2	Discovery agent	N.A.	Investigative	[31]
6,11-dihydro-5H-benzo[a]carbazole	DMSB8WQ	Discovery agent	N.A.	Investigative	[42]
6-amino-9-methoxy-7H-furo[3,2-g]chromen-7-one	DMU1CV4	Discovery agent	N.A.	Investigative	[43]
6-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMXQ8K1	Discovery agent	N.A.	Investigative	[6]
6-Bromo-4,9-dihydro-3H-beta-carboline	DM64KOZ	Discovery agent	N.A.	Investigative	[6]
6-Chloro-N-(2-morpholinoethyl)nicotinamide	DM10A9S	Discovery agent	N.A.	Investigative	[39]
6-Chloro-N-(3-morpholinopropyl)nicotinamide	DM78I4P	Discovery agent	N.A.	Investigative	[39]
6-Fluoro-N-(2-morpholinoethyl)nicotinamide	DMA1QH0	Discovery agent	N.A.	Investigative	[39]
6-Hydroxy-N-(2-morpholinoethyl)nicotinamide	DM6KVO0	Discovery agent	N.A.	Investigative	[39]
6-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMSA367	Discovery agent	N.A.	Investigative	[33]
6-Methoxy-4,9-dihydro-3H-beta-carboline	DM98FQO	Discovery agent	N.A.	Investigative	[33]
7-(3-chlorobenzyloxy)-4-carboxaldehyde-coumarin	DM762G3	Discovery agent	N.A.	Investigative	[47]
7-Acetonyloxy-3,4-cyclohexene-8-methylcoumarin	DMQCDT1	Discovery agent	N.A.	Investigative	[43]
7-Acetonyloxy-3,4-cyclopentene-8-methylcoumarin	DMQMTSX	Discovery agent	N.A.	Investigative	[43]
7-acetonyloxy-3-acetylamino-8-methoxycoumarin	DMYSNQO	Discovery agent	N.A.	Investigative	[45]
7-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMVTH0Q	Discovery agent	N.A.	Investigative	[6]
7-Bromo-4,9-dihydro-3H-beta-carboline	DMCWYT7	Discovery agent	N.A.	Investigative	[6]
7-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMQ1BE8	Discovery agent	N.A.	Investigative	[40]
7-Methoxy-9H-beta-carboline	DMHKMU1	Discovery agent	N.A.	Investigative	[6]
8-(3-Bromobenzyloxy)caffeine	DM2RA4N	Discovery agent	N.A.	Investigative	[48]
8-(3-Chlorobenzyloxy)caffeine	DM7HMNP	Discovery agent	N.A.	Investigative	[48]
8-(3-Fluorobenzyloxy)caffeine	DME85GS	Discovery agent	N.A.	Investigative	[48]
8-(3-Methoxybenzyloxy)caffeine	DMLY46X	Discovery agent	N.A.	Investigative	[48]
8-(3-Methylbenzyloxy)caffeine	DMB9645	Discovery agent	N.A.	Investigative	[48]
8-Benzyloxycaffeine	DMJQ8AP	Discovery agent	N.A.	Investigative	[48]
8-Bromo-2,3,4,9-tetrahydro-1H-beta-carboline	DMALRU4	Discovery agent	N.A.	Investigative	[6]
8-Bromo-4,9-dihydro-3H-beta-carboline	DM4V5RU	Discovery agent	N.A.	Investigative	[6]
8-Methoxy-2,3,4,9-tetrahydro-1H-beta-carboline	DMHE7J5	Discovery agent	N.A.	Investigative	[6]
8-Methoxy-4,9-dihydro-3H-beta-carboline	DM8MBSN	Discovery agent	N.A.	Investigative	[6]
8-[(3-Trifluoromethyl)benzyloxy]caffeine	DMT3IOB	Discovery agent	N.A.	Investigative	[48]
9-(3-aminopropoxy)-7H-furo[3,2-g]chromen-7-one	DM51MRV	Discovery agent	N.A.	Investigative	[45]
9-Methyl-2,3,4,9-tetrahydro-1H-beta-carboline	DMF7QS5	Discovery agent	N.A.	Investigative	[6]
Beta-methoxyamphetamine	DMA9CSG	Discovery agent	N.A.	Investigative	[49]
C-(1H-Indol-3-yl)-methylamine	DMDLK9G	Discovery agent	N.A.	Investigative	[6]
CGS-19281A	DMDB2KJ	Discovery agent	N.A.	Investigative	[33]
Cis-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	DMWX6J0	Discovery agent	N.A.	Investigative	[50]
Cis-2-phenylcyclopropylamine	DMKZ32J	Discovery agent	N.A.	Investigative	[50]
DECYL(DIMETHYL)PHOSPHINE OXIDE	DMQMR3P	Discovery agent	N.A.	Investigative	[14]
Ethyl 4-(2-oxo-2H-chromene-3-carboxamido)benzoate	DMQ3LMF	Discovery agent	N.A.	Investigative	[41]
FA-70	DMDBO89	Major depressive disorder	6A70.3	Investigative	[51]
Flavin-Adenine Dinucleotide	DM5S4GK	Discovery agent	N.A.	Investigative	[52]
HYDRAZINECARBOXAMIDE	DMARWG5	Discovery agent	N.A.	Investigative	[53]
IPRONIAZIDE	DM42ENF	Discovery agent	N.A.	Investigative	[39]
MMDA	DMUWVGP	Discovery agent	N.A.	Investigative	[52]
N'-(2-phenylallyl)hydrazine hydrochloride	DMBR1MX	Discovery agent	N.A.	Investigative	[54]
N-((1H-indol-2-yl)methyl)(phenyl)methanamine	DM093GO	Discovery agent	N.A.	Investigative	[55]
N-((1H-indol-2-yl)methyl)-2-phenylethanamine	DMYUAXR	Discovery agent	N.A.	Investigative	[55]
N-(1-Methyl-1H-indol-2-ylmethyl)-N-phenylamine	DMY3UZH	Discovery agent	N.A.	Investigative	[55]
N-(1H-Indol-2-ylmethyl)-N-(4-phenylbutyl)amine	DMHAGSW	Discovery agent	N.A.	Investigative	[55]
N-(1H-Indol-2-ylmethyl)-N-methyl-N-phenylamine	DMCM51R	Discovery agent	N.A.	Investigative	[55]
N-(1H-Indol-2-ylmethyl)-N-phenylamine	DMXD592	Discovery agent	N.A.	Investigative	[55]
N-(2-benzyl),N-(1-methylpyrrol-2-ylmethyl)amine	DM72BSO	Discovery agent	N.A.	Investigative	[30]
N-(2-Methyl-1H-indol-5-yl)cyclohexanecarboxamide	DM3SF5M	Discovery agent	N.A.	Investigative	[44]
N-(2-phenylethyl),N-(pyrrol-2-ylmethyl)amine	DM1ADE5	Discovery agent	N.A.	Investigative	[30]
N-(2-Phenylethyl)-1H-indole-2-carboxamide	DMJCO7F	Discovery agent	N.A.	Investigative	[55]
N-(3-Phenylpropyl)-1H-indole-2-carboxamide	DMKAX3Q	Discovery agent	N.A.	Investigative	[55]
N-(3-phenylpropyl)-1H-pyrrole-2-carboxamide	DMZ3I6U	Discovery agent	N.A.	Investigative	[30]
N-(4-Ethylphenyl)-2-oxo-2H-chromene-3-carboxamide	DMWTVJH	Discovery agent	N.A.	Investigative	[41]
N-(4-Phenylbutyl)-1H-indole-2-carboxamide	DMTCMUG	Discovery agent	N.A.	Investigative	[55]
N-(4-phenylbutyl)-1H-pyrrole-2-carboxamide	DMSREW5	Discovery agent	N.A.	Investigative	[30]
N-(benzyl),N-(pyrrol-2-ylmethyl)amine	DM87YJW	Discovery agent	N.A.	Investigative	[30]
N-(propargyl),N-(pyrrol-2-ylmethyl)amine	DMTJ5WL	Discovery agent	N.A.	Investigative	[30]
N-2-phenylethyl-1H-pyrrole-2-carboxamide	DM3WTDL	Discovery agent	N.A.	Investigative	[30]
N-Benzyl,N-methyl-1H-indole-2-carboxamide	DMHVRFM	Discovery agent	N.A.	Investigative	[55]
N-benzyl,N-methyl-1H-pyrrole-2-carboxamide	DM8I7N2	Discovery agent	N.A.	Investigative	[30]
N-Benzyl-(6-butoxy-2-naphthyl)-2-aminopropane	DMN9WZ3	Discovery agent	N.A.	Investigative	[26]
N-Benzyl-(6-methoxy-2-naphthyl)-2-aminopropane	DMKJ6F8	Discovery agent	N.A.	Investigative	[26]
N-Benzyl-1H-indole-2-carboxamide	DMA3YWU	Discovery agent	N.A.	Investigative	[55]
N-benzyl-1H-pyrrole-2-carboxamide	DM73ZHV	Discovery agent	N.A.	Investigative	[30]
N-Benzyl-N-(1H-indol-2-ylmethyl)-N-methylamine	DM0NJAL	Discovery agent	N.A.	Investigative	[55]
N-methyl,N-(benzyl),N-(pyrrol-2-ylmethyl)amine	DM83AEM	Discovery agent	N.A.	Investigative	[30]
N-methyl,N-(propargyl),N-(pyrrol-2-ylmethyl)amine	DMZ24XT	Discovery agent	N.A.	Investigative	[30]
N-Methyl,N-phenyl-1H-indole-2-carboxamide	DMM3B21	Discovery agent	N.A.	Investigative	[55]
N-methyl-N-(prop-2-ynyl)-1H-pyrrole-2-carboxamide	DM796AX	Discovery agent	N.A.	Investigative	[30]
N-Phenyl-1-methyl-1H-indole-2-carboxamide	DM1XV0O	Discovery agent	N.A.	Investigative	[55]
N-Phenyl-1H-indole-2-carboxamide	DM7V025	Discovery agent	N.A.	Investigative	[55]
N-phenyl-1H-pyrrole-2-carboxamide	DMBGIUE	Discovery agent	N.A.	Investigative	[30]
N-propargyl-1H-pyrrole-2-carboxamide	DMNYQ28	Discovery agent	N.A.	Investigative	[30]
N2-[4-(benzyloxy)benzyl]glycinamide	DMOZ1IY	Discovery agent	N.A.	Investigative	[56]
N2-{4-[(3-fluorobenzyl)oxy]benzyl}glycinamide	DMEWP9L	Discovery agent	N.A.	Investigative	[56]
N2-{4-[(4-chlorobenzyl)oxy]benzyl}glycinamide	DMLPJGX	Discovery agent	N.A.	Investigative	[56]
NSC-656158	DM52NOI	Discovery agent	N.A.	Investigative	[57]
Phenyl 4-(4,5-dihydro-1H-imidazol-2-yl)benzoate	DMHDWTS	Discovery agent	N.A.	Investigative	[36]
PNU-22394	DMHTPSF	Discovery agent	N.A.	Investigative	[6]
TOLOXATONE	DMHV5NK	Discovery agent	N.A.	Investigative	[58]
TRACIZOLINE	DM18CV3	Discovery agent	N.A.	Investigative	[40]
Trans-(+/-)-2-Fluoro-1,2-diphenylcyclopropylamine	DM27TPM	Discovery agent	N.A.	Investigative	[50]
Trans-2-(4-chlorophenyl)-2-fluorocyclopropanamine	DMH1S57	Discovery agent	N.A.	Investigative	[50]
Trans-2-fluoro-2-(4-fluorophenyl)cyclopropanamine	DMO01T8	Discovery agent	N.A.	Investigative	[50]
Trans-2-fluoro-2-p-tolylcyclopropanamine	DM392QT	Discovery agent	N.A.	Investigative	[50]
Trans-2-fluoro-2-phenylcyclopropylamin	DMVGAFR	Discovery agent	N.A.	Investigative	[50]
TRYPTOLINE	DMV19K7	Discovery agent	N.A.	Investigative	[40]

References

• [1] Further investigation into the mechanism of tachykinin NK(2) receptor-triggered serotonin release from guinea-pig proximal colon. J Pharmacol Sci. 2009 May;110(1):122-6.
• [2] MAOIs in the contemporary treatment of depression. Neuropsychopharmacology. 1995 May;12(3):185-219.
• [3] Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings. Hum Psychopharmacol. 2002 Dec;17(8):401-5.
• [4] Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice. Int J Neuropsychopharmacol. 2009 Mar 11:1-11.
• [5] Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Pharmacol Toxicol. 2001 Feb;88(2):75-80.
• [6] Binding of beta-carbolines at imidazoline I2 receptors: a structure-affinity investigation. Bioorg Med Chem Lett. 2004 Feb 23;14(4):999-1002.
• [7] Emerging drugs in neuropathic pain. Expert Opin Emerg Drugs. 2007 Mar;12(1):113-26.
• [8] Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157. Neuropsychopharmacology. 2010 Feb;35(3):623-31.
• [9] Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment. Curr Drug Targets. 2012 Apr;13(4):483-94.
• [10] Proposed structural basis of interaction of piperine and related compounds with monoamine oxidases. Bioorg Med Chem Lett. 2010 Jan 15;20(2):537-40.
• [11] Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral doses. Methods Find Exp Clin Pharmacol. 2008 Mar;30(2):141-7.
• [12] Novel monoamine oxidase inhibitors: a patent review (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):91-110.
• [13] LSD1 inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2016 May;26(5):565-80.
• [14] The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
• [15] MAO inhibitors and their wider applications: a patent review.Expert Opin Ther Pat. 2018 Mar;28(3):211-226.
• [16] A patent review of butyrylcholinesterase inhibitors and reactivators 2010-2017.Expert Opin Ther Pat. 2018 Jun;28(6):455-465.
• [17] Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile. J Pharmacol Exp Ther. 1996 Apr;277(1):265-77.
• [18] Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors. J Neural Transm Suppl. 1989;28:5-20.
• [19] Mechanisms of spinal reflex depressant effects of CS-722, a newly synthesized centrally acting muscle relaxant, in spinal rats. Neuropharmacology. 1992 Sep;31(9):949-54.
• [20] MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography. Eur J Clin Pharmacol. 1997;52(2):121-8.
• [21] Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase. Xenobiotica. 2005 Jun;35(6):561-73.
• [22] Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor. Clin Neuropharmacol. 1993;16 Suppl 2:S25-33.
• [23] 4-(O-benzylphenoxy)-N-methylbutylamine (bifemelane) and other 4-(O-benzylphenoxy)-N-methylalkylamines as new inhibitors of type A and B monoamine oxidase. J Neurochem. 1988 Jan;50(1):243-7.
• [24] Species differences and mechanism of the epimerization of a new MAO-A inhibitor. Xenobiotica. 1998 Mar;28(3):269-80.
• [25] 2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1388-95.
• [26] Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors. Bioorg Med Chem. 2009 Mar 15;17(6):2452-60.
• [27] Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)ox... J Med Chem. 2009 Nov 12;52(21):6685-706.
• [28] Inhibition of monoamine oxidase by (E)-styrylisatin analogues. Bioorg Med Chem Lett. 2009 May 1;19(9):2509-13.
• [29] Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. J Med Chem. 2002 Nov 21;45(24):5260-79.
• [30] New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. J Med Chem. 2007 Mar 8;50(5):922-31.
• [31] 3-(1H-Pyrrol-1-yl)-2-oxazolidinones as reversible, highly potent, and selective inhibitors of monoamine oxidase type A. J Med Chem. 2002 Mar 14;45(6):1180-3.
• [32] Human and rat monoamine oxidase-A are differentially inhibited by (S)-4-alkylthioamphetamine derivatives: insights from molecular modeling studies. Bioorg Med Chem. 2007 Aug 1;15(15):5198-206.
• [33] Pyrazino[1,2-a]indoles as novel high-affinity and selective imidazoline I(2) receptor ligands. Bioorg Med Chem Lett. 2004 Feb 23;14(4):1003-5.
• [34] Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Bioorg Med Chem Lett. 2006 Mar 15;16(6):1753-6.
• [35] Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Bioorg Med Chem. 2010 Jul 15;18(14):5063-70.
• [36] Ultrasound promoted synthesis of 2-imidazolines in water: a greener approach toward monoamine oxidase inhibitors. Bioorg Med Chem Lett. 2009 Jan 15;19(2):546-9.
• [37] 3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (Amifuraline), a promising reversible and selective peripheral MAO-A inhibitor. J Med Chem. 2006 Sep 7;49(18):5578-86.
• [38] Probes for imidazoline binding sites: synthesis and evaluation of a selective, irreversible I2 ligand. Bioorg Med Chem Lett. 2000 Mar 20;10(6):605-7.
• [39] Design of novel nicotinamides as potent and selective monoamine oxidase a inhibitors. Bioorg Med Chem. 2010 Feb 15;18(4):1659-64.
• [40] Binding of an imidazopyridoindole at imidazoline I2 receptors. Bioorg Med Chem Lett. 2004 Jan 19;14(2):527-9.
• [41] Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem. 2009 Apr 9;52(7):1935-42.
• [42] Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives. J Med Chem. 2007 Nov 1;50(22):5364-71.
• [43] Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008 Nov 13;51(21):6740-51.
• [44] Inhibition of monoamine oxidase by indole and benzofuran derivatives. Eur J Med Chem. 2010 Oct;45(10):4458-66.
• [45] A QSAR model for in silico screening of MAO-A inhibitors. Prediction, synthesis, and biological assay of novel coumarins. J Med Chem. 2006 Feb 9;49(3):1149-56.
• [46] New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A ... Bioorg Med Chem. 2009 Jan 15;17(2):675-89.
• [47] Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem. 2007 Nov 15;50(23):5848-52.
• [48] Inhibition of monoamine oxidase by 8-benzyloxycaffeine analogues. Bioorg Med Chem. 2010 Feb;18(3):1018-28.
• [49] Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2000 Aug;24(6):955-77.
• [50] Fluorinated phenylcyclopropylamines. Part 5: Effects of electron-withdrawing or -donating aryl substituents on the inhibition of monoamine oxidases... Bioorg Med Chem. 2008 Aug 1;16(15):7148-66.
• [51] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2489).
• [52] How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
• [53] Fluorinated phenylcyclopropylamines. 2. Effects of aromatic ring substitution and of absolute configuration on inhibition of microbial tyramine oxi... J Med Chem. 2004 Nov 18;47(24):5860-71.
• [54] Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity. J Med Chem. 2006 Apr 6;49(7):2166-73.
• [55] Synthesis, structure-activity relationships and molecular modeling studies of new indole inhibitors of monoamine oxidases A and B. Bioorg Med Chem. 2008 Nov 15;16(22):9729-40.
• [56] Solid-phase synthesis and insights into structure-activity relationships of safinamide analogues as potent and selective inhibitors of type B monoa... J Med Chem. 2007 Oct 4;50(20):4909-16.
• [57] Synthesis and preclinical evaluations of 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one monosodium phosphate (CHM-1-P-Na) as a potent antitumo... J Med Chem. 2010 Feb 25;53(4):1616-26.
• [58] Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and ... J Nat Prod. 2006 Jun;69(6):945-9.